Alachua will be home to Coqui RadioPharmaceuticals' $250 million medical radioisotope production facility. The facility is expected to employ 164 people with an average salary of $75,000. The facility will be located on 25 acres of land south of Progress Park that is owned by the University of Florida.
Coqui chose Alachua for proximity to UF’s nuclear research reactor. The location will allow the pharmaceutical company to collaborate with UF engineering and medical researchers, and will be near Progress Park, a medical research and biotech park. The facility will also provide job opportunities for both UF and Santa Fe College graduates. Alachua County is honored to have Coqui here as a part of the growing community.
Coqui RadioPharmaceuticals incorporated in 2009 to address the worldwide shortage of Molybdenum-99. MO-99, used in medical diagnoses and treatments for diseases including Cancer, Alzheimer’s, renal disease, and bone traumas, is utilized in approximately 18 million procedures in the U.S. and 30 million worldwide. Coqui will be the first company in the U.S. to produce MO-99. After submitting an application to the Nuclear Regulatory Commission in mid-2015, the company could begin construction in late 2016 or early 2017 and begin manufacturing in 2020. Coqui has selected INVAP, an Argentine firm, to design and construct the new facility. The facility will include two research-scale nuclear reactors that use low-enriched uranium.